FDA drug safety communication: FDA warns about several safety issues with opioid pain medicines; requires label changes

Home → Pain → FDA drug safety communication: FDA warns about several safety issues with opioid pain medicines; requires label changes

FDA What’s New: Drugs

Local Healthcare